These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2540247)
1. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. Plotkin SA; Starr SE; Friedman HM; Gönczöl E; Weibel RE J Infect Dis; 1989 May; 159(5):860-5. PubMed ID: 2540247 [TBL] [Abstract][Full Text] [Related]
2. A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men. Adler SP; Manganello AM; Lee R; McVoy MA; Nixon DE; Plotkin S; Mocarski E; Cox JH; Fast PE; Nesterenko PA; Murray SE; Hill AB; Kemble G J Infect Dis; 2016 Nov; 214(9):1341-1348. PubMed ID: 27521362 [TBL] [Abstract][Full Text] [Related]
3. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. Adler SP; Starr SE; Plotkin SA; Hempfling SH; Buis J; Manning ML; Best AM J Infect Dis; 1995 Jan; 171(1):26-32. PubMed ID: 7798679 [TBL] [Abstract][Full Text] [Related]
4. Vaccines for the prevention of human cytomegalovirus infection. Plotkin SA; Starr SE; Friedman HM; Gonczol E; Brayman K Rev Infect Dis; 1990; 12 Suppl 7():S827-38. PubMed ID: 2173112 [TBL] [Abstract][Full Text] [Related]
5. Development of a cytomegalovirus vaccine: lessons from recent clinical trials. Gonczol E; Plotkin S Expert Opin Biol Ther; 2001 May; 1(3):401-12. PubMed ID: 11727514 [TBL] [Abstract][Full Text] [Related]
6. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Quinnan GV; Delery M; Rook AH; Frederick WR; Epstein JS; Manischewitz JF; Jackson L; Ramsey KM; Mittal K; Plotkin SA Ann Intern Med; 1984 Oct; 101(4):478-83. PubMed ID: 6089634 [TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine. Gerna G; Lilleri D New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581 [TBL] [Abstract][Full Text] [Related]
8. Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo. Suárez NM; Lau B; Kemble GM; Lee R; Mocarski ES; Wilkinson GWG; Adler SP; McVoy MA; Davison AJ Virus Genes; 2017 Aug; 53(4):650-655. PubMed ID: 28391502 [TBL] [Abstract][Full Text] [Related]
9. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181 [TBL] [Abstract][Full Text] [Related]
10. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Plotkin SA; Starr SE; Friedman HM; Brayman K; Harris S; Jackson S; Tustin NB; Grossman R; Dafoe D; Barker C Ann Intern Med; 1991 Apr; 114(7):525-31. PubMed ID: 1848053 [TBL] [Abstract][Full Text] [Related]
11. The status of cytomegalovirus vaccine. Starr SE; Friedman HM; Plotkin SA Rev Infect Dis; 1991; 13 Suppl 11():S964-5. PubMed ID: 1664136 [TBL] [Abstract][Full Text] [Related]
12. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex. Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model. Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990 [TBL] [Abstract][Full Text] [Related]
14. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376 [TBL] [Abstract][Full Text] [Related]